Wird geladen...

In Vivo Stabilization of a Gastrin-Releasing Peptide Receptor Antagonist Enhances PET Imaging and Radionuclide Therapy of Prostate Cancer in Preclinical Studies

A single tool for early detection, accurate staging, and personalized treatment of prostate cancer (PCa) would be a major breakthrough in the field of PCa. Gastrin-releasing peptide receptor (GRPR) targeting peptides are promising probes for a theranostic approach for PCa overexpressing GRPR. Howeve...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Theranostics
Hauptverfasser: Chatalic, Kristell L.S., Konijnenberg, Mark, Nonnekens, Julie, de Blois, Erik, Hoeben, Sander, de Ridder, Corrina, Brunel, Luc, Fehrentz, Jean-Alain, Martinez, Jean, van Gent, Dik C., Nock, Berthold A., Maina, Theodosia, van Weerden, Wytske M., de Jong, Marion
Format: Artigo
Sprache:Inglês
Veröffentlicht: Ivyspring International Publisher 2016
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4679358/
https://ncbi.nlm.nih.gov/pubmed/26722377
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.13580
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!